Korea

HanAll Biopharma Announces Initiation of Phase III Randomized, Double-Masked Vehicle Controlled VELOS-4 Trial Evaluating Tanfanercept for Treatment of Dry Eye Disease

* HanAll has initiated a Phase III VELOS-4 study to evaluate the efficacy and safety of tanfanercept in dry eye based on the findings from the previous Phase III VELOS-3 study. * Tanfanercept demonstrated statistically significant improvement on the secondary outcome measure, Schirmer testing...

2024-05-03 19:00 803

QANDA Named to TIME's Inaugural List of the World's Top EdTech Companies in 2024

LOS ANGELES, May 2, 2024 /PRNewswire/ -- Mathpresso, creator of Asia's leading learning app, QANDA, today announced that it has been recognized byTIME's World's Top EdTech Companies in 2024 . Presented by TIME and Statista Inc., this...

2024-05-03 07:27 942

Boryung Launches 2024 Humans In Space Challenge: Sending Experiments into Orbit

* Boryung to support the launch of space experiments into orbit for selected startups and researchers * Held for the third consecutive year, HIS presents an expanded ecosystem of engagements with NASA, ISS National Lab,MIT, and major space companies * Humans In Space(HIS) will serve as a glo...

2024-05-02 20:00 874

Hanwha Launches Engine Leasing Platform

* South Korea's 7th largest business enterprise has launched 'Hanwha Aviation', an engine leasing and trading platform with a long-term vertically integrated strategy for newer generation assets. * Hanwha will apply extensive experience and expertise in aero engines, finance, and asset manage...

2024-05-02 17:30 701

Korea Electric Power Corporation Files 2023 Annual Report on Form 20-F

NAJU, South Korea, April 30, 2024 /PRNewswire/ -- On April 30, 2024, Korea Electric Power Corporation (NYSE: KEP) ("KEPCO") filed its annual report including audited consolidated financial statements on Form 20-F for the year endedDecember 31, 2023 with the U.S. Securities and Exchange Commission...

2024-05-01 04:22 1642

Bebefinn Expands with Its First Live Show, "Bebefinn LIVE - Bedtime Adventure"

* In partnership with Biz Trends Media, Bebefinn LIVE - Bedtime Adventure will debut inHong Kong on May 12, and tour Singapore this summer * Pinkfong's latest hit, Bebefinn, builds a global fanbase beyond the screen through its first live stage show, merchandise, a branded app, and more Click ...

2024-04-30 21:05 940

HanAll Biopharma Reports Q1 2024 Financial Results and Provides Business Update

* Delivered solid performance to start 2024, with record-breaking first quarter revenue of34.1 billion KRW. Strong sales momentum continued from key products, funding investments in ongoing R&D programs. * Phase 3 VELOS-4 study of tanfanercept in dry eye disease expected to be initiated in th...

2024-04-30 19:00 791

KT Corp. Files 2023 Annual Report on Form 20-F

SEOUL, South Korea, April 30, 2024 /PRNewswire/ -- KT Corporation (NYSE: KT ), South Korea's largest integrated telecom and digital platform service provider, announced that it has filed its Form 20- F Annual Report onApril 30th , 2024 for the year ended December 31, 2023 with the Securities and Ex...

2024-04-30 18:49 1660

Hurom Takes Global Action to Protect Juicer Patents

Protecting Proprietary Technologies and Fostering a Healthy Global Ecosystem SEOUL, South Korea, April 29, 2024 /PRNewswire/ -- Hurom, a pioneer in the development of the slow juicer and a leader in the global market, is stepping up efforts to safeguard patent rights worldwide to protect its prop...

2024-04-29 21:00 986

Medit launches the revolutionary i900, an intraoral scanning system set to redefine the scanning experience for dental clinics worldwide

* The Medit i900 features cutting-edge technology for smoother, easier scanning, comfortable handling, and improved scan quality SEOUL, South Korea and LONG BEACH, Calif., April 29, 2024 /PRNewswire/ -- Medit (www.medit.com ), a leading provider of dental 3D scanners and ...

2024-04-29 21:00 1046

WOORI FINANCIAL GROUP INC. FILES ITS ANNUAL REPORT ON FORM 20-F

SEOUL, South Korea, April 29, 2024 /PRNewswire/ -- On April 29, 2024, Woori Financial Group Inc. (NYSE:WF) (KRX:316140) filed its Annual Report on Form 20-F for the year endedDecember 31, 2023 with the U.S. Securities and Exchange Commission. The 2023 Annual Report on Form 20-F can be downloaded ...

2024-04-29 20:25 1526

POSCO HOLDINGS INC. Files its Annual Report on Form 20-F

SEOUL, South Korea, April 29, 2024 /PRNewswire/ -- On April 29, 2024, POSCO HOLDINGS INC. (NYSE: PKX) filed its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission. The 2023 Annual Report on Form 20-F can be downloaded from www.posco-in...

2024-04-29 19:26 1510

SK TELECOM CO. LTD. FILES ITS ANNUAL REPORT ON FORM 20-F

SEOUL, South Korea, April 29, 2024 /PRNewswire/ -- On April 29, 2024, SK Telecom Co., Ltd. filed its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission. The 2023 Annual Report on Form 20-F can be viewed onwww.sktelecom.com

2024-04-29 19:25 1491

Driving Impact with AI: Brian Impact Foundation Joins AVPN Global Conference 2024

* Brian Impact attends Asian Venture Philanthropy Network Global Conference 2024 to discuss foundation's AI-powered assistance system, 'BEES (Benevolence Enhancing Expert System)' * Incorporating large language models, BEES enables effective data-driven decision-making * Panel discussion on...

2024-04-26 20:00 1358

KB FINANCIAL GROUP INC. FILES ITS ANNUAL REPORT ON FORM 20-F

SEOUL, South Korea, April 26, 2024 /PRNewswire/ -- On April 26, 2024, KB Financial Group Inc. filed its Annual Report on Form 20-F for the year ended December 31, 2023 with the U.S. Securities and Exchange Commission. The 2023 Annual Report on Form 20-F can be downloaded from www.kbfg.com

2024-04-26 19:34 1801

Hyundai Bioscience's antiviral for Dengue Fever to enter clinical trials in Brazil

* "Aiming to offer a Dengue antiviral treatment course in $100 price range" * Hyundai Bioscience decides to conduct dengue clinical trials in Brazil, which has the largest number of Dengue patients and offers a fast-track approval SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Hyundai Biosc...

2024-04-25 21:41 1119

On-Device AI Healthcare Company Noul Announces 2 Clinical Performance Studies at Pan-African Malaria Conference

* miLab showed almost equivalent to WHO-certified first-degree microscopy experts: Sensitivity of 94.4%, Specificity of 98.1% * African authority on malaria diagnosis said "miLab is a potential game changer in accelerating access to parasitological confirmation" YONGIN, South Korea, April 25,...

2024-04-25 21:00 1198

LG Innotek awarded at 'Edison Awards,' the most prestigious invention award in the US for the second consecutive year

Achieved high-definition image at the level of DSLR cameras with a smartphone * 'High Magnification Optical Continuous Zoom Camera Module'…World's first mass production in 2022 * Innovative optical camera technology is increasingly being used in a variety of applications, including vehicles a...

2024-04-25 20:00 999

POSCO International achieves solid first quarter results for fiscal year 2024 despite global economic downturn

* On the 25th, announced 1Q revenue of 7.8 trillion won and operating profit of265 billion won * Stable profit structure of the energy business value chain and increased sales to the eco-friendly industry customers contributed to profit growth * Secured a stable cash flow foundation to suppo...

2024-04-25 18:41 876

Hyundai Bioscience Announces Clinical Development Plan for Niclosamide-based Metabolic Anticancer Drug Targeting P53 Mutation Cancer

* The only solution for intractable cancer caused by mutations in the p53 gene * Planning clinical trials targeting cancer patients with no available treatment due to p53 gene mutations SEOUL, South Korea, April 25, 2024 /PRNewswire/ -- Hyundai Bioscience announced onApril 25th that its clinica...

2024-04-25 17:11 1004
12345 ... 99